You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 9, September 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Early Treatment Diabetic Retinopathy Study Research Group


OBJECTIVE: To determine whether the efficacy of photocoagulation treatment of diabetic macular edema may be influenced by degree of capillary closure, severity or source of fluorescein leakage, extent of retinal edema, presence of cystoid changes, or severity of hard exudates. PATIENTS: Patients with mild to moderate nonproliferative diabetic retinopathy and macular edema definitely or questionably involving the center of the macula. DESIGN: One eye of each patient was assigned to early photocoagulation; the other was assigned to deferral of photocoagulation, with follow-up visits scheduled every 4 months and photocoagulation to be carried out promptly if high-risk proliferative retinopathy developed. In this report, the beneficial effect of photocoagulation was examined in subgroups defined by severity of the characteristics specified above. RESULTS: We found no subgroup in which eyes that were assigned to immediate focal treatment had a less favorable visual acuity outcome than those that were assigned to deferral (ie, no qualitative interaction). CONCLUSIONS: Focal photocoagulation should be considered for eyes with clinically significant macular edema, particularly when the center of the macula is involved or imminently threatened. Trends for treatment effect to be less in eyes with less extensive retinal thickening and less thickening at the center of the macula support our previous recommendation that, for such eyes, an initial period of close observation may be preferable to immediate treatment, particularly when most of the leakage to be treated arises close to the center of the macula, increasing the risk of damage to it from direct treatment or subsequent migration of treatment scars.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Comparison of Time-Domain OCT and Fundus Photographic Assessments of Retinal Thickening in Eyes with Diabetic Macular Edema
Davis et al.
IOVS 2008;49:1745-1752.
ABSTRACT | FULL TEXT  

Screening for and managing diabetic retinopathy: Current approaches
Bloomgarden
Am J Health Syst Pharm 2007;64:S8-S14.
ABSTRACT | FULL TEXT  

Management of Diabetic Retinopathy: A Systematic Review
Mohamed et al.
JAMA 2007;298:902-916.
ABSTRACT | FULL TEXT  

Combined triamcinolone acetonide injection and grid laser photocoagulation: a promising treatment for diffuse diabetic macular oedema?
Iida
Br. J. Ophthalmol. 2007;91:407-408.
FULL TEXT  

Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema
Shimura et al.
Br. J. Ophthalmol. 2007;91:449-454.
ABSTRACT | FULL TEXT  

Agreement of the Heidelberg Retina Tomograph II Macula Edema Module With Fundus Biomicroscopy in Diabetic Maculopathy.
Kisilevsky et al.
Arch Ophthalmol 2006;124:337-342.
ABSTRACT | FULL TEXT  

Impaired retinal autoregulation in small retinal arterioles before and after focal laser treatment for diabetic maculopathy
Jeppesen and Bek
Br. J. Ophthalmol. 2006;90:198-201.
ABSTRACT | FULL TEXT  

The Effect of Ruboxistaurin on Visual Loss in Patients With Moderately Severe to Very Severe Nonproliferative Diabetic Retinopathy: Initial Results of the Protein Kinase C {beta} Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial
The PKC-DRS Study Group
Diabetes 2005;54:2188-2197.
ABSTRACT | FULL TEXT  

Addition of Primary Care-Based Retinal Imaging Technology to an Existing Eye Care Professional Referral Program Increased the Rate of Surveillance and Treatment of Diabetic Retinopathy
Wilson et al.
Diabetes Care 2005;28:318-322.
ABSTRACT | FULL TEXT  

Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema
Luttrull et al.
Br. J. Ophthalmol. 2005;89:74-80.
ABSTRACT | FULL TEXT  

Correlation of a scanning laser derived oedema index and visual function following grid laser treatment for diabetic macular oedema
Hudson et al.
Br. J. Ophthalmol. 2003;87:455-461.
ABSTRACT | FULL TEXT  

Quantitative Assessment of the Integrity of the Blood-Retinal Barrier in Mice
Derevjanik et al.
IOVS 2002;43:2462-2467.
ABSTRACT | FULL TEXT  

Factors Associated With Implementation of Preventive Care Measures in Patients With Diabetes Mellitus
Streja and Rabkin
Arch Intern Med 1999;159:294-302.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.